Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
meeting tags : Disease save search
Alterity Therapeutics Parkinson’s Disease and Multiple System Atrophy Data Featured at the American Academy of Neurology (AAN) 2024 Annual Meeting
Published: 2024-04-17 (Crawled : 01:00) - alteritytherapeutics.com
ATHE | $2.04 -4.67% -4.9% 54K
|
Health Technology
|
| O: 0.0%
H: 7.32%
C: -1.95%
disease neurology system meeting parkinson’s therapeutics
Zevra Therapeutics Presents New Data on the Long-Term Safety and Efficacy of Arimoclomol as a Treatment for Niemann-Pick Disease Type C at the SIMD 45th Annual Meeting
Published: 2024-04-15 (Crawled : 21:00) - globenewswire.com
ZVRA | $4.515 0.33% 0.33% 360K
|
n/a
|
| O: 1.15%
H: 1.03%
C: -1.45%
disease treatment for meeting therapeutics
Biomica to Present at Digestive Disease Week (DDW) Conference 2024 Annual Meeting
Published: 2024-04-11 (Crawled : 11:00) - prnewswire.com
EVGN | $0.7 -13.64% 63K
|
Health Technology
|
| O: -0.87%
H: 0.0%
C: 0.0%
conference disease meeting week
iCAD’s ProFound AI Suite Uncovers Hidden Heart Disease Risk According to New Data Presented at American College of Cardiology Meeting
Published: 2024-04-08 (Crawled : 21:00) - globenewswire.com
ICAD | $1.54 -3.15% -3.25% 68K
|
Technology Services
|
| O: 5.7%
H: 11.98%
C: 7.78%
disease risk meeting heart cardiology
Blueprint Medicines Highlights AYVAKIT® (avapritinib) Long-Term Efficacy and Safety Data and Advances in Mast Cell Disease Research at 2024 AAAAI Annual Meeting
Published: 2024-02-23 (Crawled : 13:00) - prnewswire.com
BPMC | $86.87 -2.28% -2.34% 800K
|
Health Technology
|
| O: 0.8%
H: 5.19%
C: 3.23%
ayvakit disease cell research meeting
Cyclo Therapeutics Announces Positive Outcome from Type C Meeting with the U.S. FDA Discussing Trappsol® Cyclo™ Clinical Program for the Treatment of Niemann-Pick Disease Type C1
Published: 2023-12-18 (Crawled : 23:00) - biospace.com/
CYTH | $1.19 -0.83% -0.84% 57K
|
Professional, Scientific, and T...
|
| O: 8.03%
H: 0.54%
C: -6.76%
trappsol fda disease positive treatment meeting program therapeutics
Biomea Fusion Presents Achievement of Minimal Residual Disease Negativity (MRD-neg) in First Complete Responder from Ongoing Phase I Study (COVALENT-101) of BMF-219 in Patients with Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) at the 2023 ASH Annual Meeting
Published: 2023-12-11 (Crawled : 14:30) - globenewswire.com
BMEA | $10.87 -2.6% -2.67% 1.3M
|
Professional, Scientific, and T...
|
| O: -24.51%
H: 1.49%
C: -7.69%
alent-101 first disease ongoing bmf-219 meeting leukemia study
Agios Presents Positive Results from Phase 2 Portion of the RISE UP Pivotal Study in Sickle Cell Disease at 65th ASH Annual Meeting and Exposition
Published: 2023-12-10 (Crawled : 00:20) - globenewswire.com
AGIO | $29.52 0.31% 0.3% 750K
|
Health Technology
| Email alert
Add to watchlist
disease positive cell meeting results study
60 Degrees Pharma Announces Type C Meeting with FDA to Discuss Development of Tafenoquine for Babesiosis, an Emerging Tick-Borne Disease
Published: 2023-11-15 (Crawled : 12:30) - globenewswire.com
SXTP | $0.245 -0.57% -0.57% 92K
|
n/a
|
| O: 10.27%
H: 14.17%
C: 6.95%
technology fda pharma disease meeting tick-borne disease
BioVie Presents Positive Clinical Safety Data from Phase 2b Trial of BIV201 in Refractory Ascites at the American Association for the Study of Liver Disease (AASLD) - The Liver Meeting® 2023
Published: 2023-11-13 (Crawled : 13:30) - globenewswire.com
BIVI | $0.4874 -0.21% -0.21% 490K
|
Health Technology
|
| O: -4.57%
H: 1.5%
C: 0.0%
biv201 meeting liver disease association positive trial study
ENDRA to Host Multidisciplinary Clinical Discussion on Managing Liver Disease During AASLD’s The Liver Meeting® 2023
Published: 2023-11-06 (Crawled : 14:00) - biospace.com/
NDRA | $0.2334 1.11% 68K
|
Health Technology
|
| O: 3.13%
H: 4.03%
C: -5.05%
meeting liver disease
CRISPR Therapeutics Announces Completion of FDA Advisory Committee Meeting for Exagamglogene Autotemcel (exa-cel) for Severe Sickle Cell Disease
Published: 2023-10-31 (Crawled : 22:00) - globenewswire.com
CRSP M | $55.04 -1.99% -2.03% 1.8M
|
Health Technology
|
| O: 11.61%
H: 1.63%
C: 0.69%
fda crispr disease cell meeting therapeutics
Biogen to Present New Data at the Clinical Trials on Alzheimer’s Disease (CTAD) 2023 Meeting
Published: 2023-10-19 (Crawled : 12:00) - globenewswire.com
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: -2.33%
disease alzheimer’s trials meeting
AbbVie's SKYRIZI® (risankizumab) Versus STELARA® (ustekinumab) Head-to-Head Study in Crohn's Disease Meets All Primary and Secondary Endpoints
Published: 2023-10-15 (Crawled : 16:20) - prnewswire.com
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
| Email alert
Add to watchlist
skyrizi disease study
Sight Sciences Announces Presentation of Successful Phase I Results of the SAHARA Randomized Controlled Clinical Trial Comparing TearCare® to Restasis® for the Treatment of Dry Eye Disease at the American Academy of Optometry Annual Meeting
Published: 2023-10-12 (Crawled : 20:00) - globenewswire.com
SGHT | $5.14 -1.91% -1.95% 130K
|
|
| O: -0.77%
H: 1.81%
C: -2.07%
tearcare disease presentation treatment sciences meeting eye trial results
PepGen Announces Presentations at the 2023 Myotonic Dystrophy Foundation Annual Conference, Ottawa Neuromuscular Disease Meeting, and H.C. Wainwright 25th Annual Global Investment Conference
Published: 2023-09-01 (Crawled : 12:00) - globenewswire.com
PEPG | $10.59 -10.6% -11.85% 120K
|
|
| O: 2.22%
H: 2.87%
C: 0.31%
conference disease global
bluebird bio Confirms That FDA Has Communicated That Advisory Committee Meeting Will Not Be Scheduled for lovo-cel Gene Therapy for Sickle Cell Disease
Published: 2023-08-16 (Crawled : 13:00) - biospace.com/
BLUE | $1.02 7.03% 6.11% 8.2M
|
Health Technology
|
| O: -1.66%
H: 2.81%
C: 0.28%
fda disease cell meeting therapy
180 Life Sciences Provides Update on Regulatory Approval Process in the UK and US for Dupuytren’s Disease Treatment; Continues Consultations with the UK MHRA and Initiates a Type C Meeting Request With the US FDA
Published: 2023-08-03 (Crawled : 12:00) - globenewswire.com
ATNF | $1.87 2.19% 2.14% 20K
|
|
| O: -3.3%
H: 4.53%
C: 1.02%
fda disease life approval update sciences meeting
New Data Presented at the Infectious Disease Society for Obstetrics and Gynecology (IDSOG) Annual Meeting Differentiate Talis Biomedical’s Women’s and Sexual Health Product Menu
Published: 2023-07-27 (Crawled : 12:00) - globenewswire.com
TLIS | $9.0 4.57% 12K
|
|
| O: 3.88%
H: 0.52%
C: -2.58%
disease health meeting
INmune Bio Inc. Announces Data Presented at the 16th European Meeting on Glial Cells in Health and Disease Shows that XPro™ Promotes Remyelination by Affecting Astroglial and Microglial Biology
Published: 2023-07-10 (Crawled : 20:00) - globenewswire.com
INMB | $8.33 -5.34% -5.64% 69K
|
Health Technology
|
| O: 2.54%
H: 11.34%
C: 11.34%
disease health meeting
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.